Volume 58, Issue 1, Pages (July 2010)

Slides:



Advertisements
Similar presentations
Volume 61, Issue 5, Pages (May 2012)
Advertisements

Volume 68, Issue 6, Pages (December 2015)
Volume 58, Issue 2, Pages (August 2010)
Volume 67, Issue 3, Pages (March 2015)
European Urology Focus
Volume 187, Issue 4, Pages e515-e516 (April 2012)
Volume 66, Issue 6, Pages (December 2014)
Epidemiology and Risk Factors of Urothelial Bladder Cancer
Volume 60, Issue 2, Pages (August 2011)
Volume 57, Issue 6, Pages (June 2010)
Volume 199, Issue 4, Pages e235-e236 (April 2018)
Volume 49, Issue 2, Pages (February 2006)
Volume 61, Issue 5, Pages (May 2012)
Volume 63, Issue 4, Pages (April 2013)
Volume 67, Issue 3, Pages (March 2015)
Volume 68, Issue 3, Pages (September 2015)
Volume 51, Issue 3, Pages (March 2007)
Volume 60, Issue 5, Pages (November 2011)
Volume 63, Issue 3, Pages e39-e40 (March 2013)
Volume 71, Issue 6, Pages e171-e172 (June 2017)
Volume 72, Issue 5, Pages (November 2017)
Volume 61, Issue 4, Pages (April 2012)
Volume 66, Issue 3, Pages (September 2014)
Volume 56, Issue 3, Pages (September 2009)
Volume 63, Issue 4, Pages (April 2013)
Volume 64, Issue 4, Pages (October 2013)
Volume 67, Issue 4, Pages (April 2015)
Volume 63, Issue 1, Pages (January 2013)
Volume 64, Issue 4, Pages (October 2013)
Bladder Cancer: A Major Public Health Issue
Volume 59, Issue 6, Pages (June 2011)
Nomograms for Bladder Cancer
Precystectomy Nomogram for Prediction of Advanced Bladder Cancer Stage
The Importance of Transurethral Resection in Managing Patients With Urothelial Cancer in the Bladder: Proposal for a Transurethral Resection of Bladder.
Volume 67, Issue 2, Pages (February 2015)
Volume 61, Issue 5, Pages (May 2012)
Volume 52, Issue 5, Pages (November 2007)
Volume 58, Issue 4, Pages (October 2010)
CEACAM1: A Novel Urinary Marker for Bladder Cancer Detection
Volume 57, Issue 4, Pages (April 2010)
Volume 68, Issue 1, Pages (July 2015)
Volume 61, Issue 6, Pages (June 2012)
Volume 69, Issue 3, Pages (March 2016)
Volume 64, Issue 3, Pages (September 2013)
Volume 61, Issue 3, Pages (March 2012)
Volume 61, Issue 5, Pages (May 2012)
Volume 66, Issue 6, Pages (December 2014)
Volume 66, Issue 6, Pages (December 2014)
Volume 67, Issue 6, Pages (June 2015)
Long-term Cancer-specific Survival in Patients with High-risk, Non–muscle-invasive Bladder Cancer and Tumour Progression: A Systematic Review  Sven van.
Volume 62, Issue 2, Pages (August 2012)
Volume 59, Issue 1, Pages (January 2011)
Volume 60, Issue 6, Pages (December 2011)
Volume 56, Issue 5, Pages (November 2009)
Volume 53, Issue 1, Pages (January 2008)
Volume 69, Issue 6, Pages (June 2016)
Volume 62, Issue 3, Pages (September 2012)
Testicular Cancer Variations in Time and Space in Europe
Volume 74, Issue 4, Pages (October 2018)
European Urology Oncology
Psychotherapeutic Interventions Targeting Prostate Cancer Patients: A Systematic Review of the Literature  Liliana Vartolomei, Shahrokh F. Shariat, Mihai.
Volume 54, Issue 2, Pages (August 2008)
Volume 54, Issue 1, Pages (July 2008)
Georges-Pascal Haber, Sebastien Crouzet, Inderbir S. Gill 
Volume 52, Issue 4, Pages (October 2007)
Volume 53, Issue 2, Pages (February 2008)
Early Single-Instillation Chemotherapy Has No Real Benefit and Should Be Abandoned in Non–Muscle-Invasive Bladder Cancer  Sten Holmäng  European Urology.
Volume 52, Issue 1, Pages (July 2007)
Volume 54, Issue 1, Pages (July 2008)
Volume 51, Issue 5, Pages (May 2007)
Presentation transcript:

Volume 58, Issue 1, Pages 112-117 (July 2010) Validation of the AJCC TNM Substaging of pT2 Bladder Cancer: Deep Muscle Invasion Is Associated with Significantly Worse Outcome  Derya Tilki, Oliver Reich, Pierre I. Karakiewicz, Giacomo Novara, Wassim Kassouf, Süleyman Ergün, Yves Fradet, Vincenzo Ficarra, Guru Sonpavde, Christian G. Stief, Eila Skinner, Robert S. Svatek, Yair Lotan, Arthur I. Sagalowsky, Shahrokh F. Shariat  European Urology  Volume 58, Issue 1, Pages 112-117 (July 2010) DOI: 10.1016/j.eururo.2010.01.015 Copyright © 2010 European Association of Urology Terms and Conditions

Fig. 1 Probability estimates of (A) recurrence-free and (B) cancer-specific survival in 565 patients with pT2 urothelial carcinoma of the bladder (UCB) at radical cystectomy (RC) stratified by pT2 substage. Probability estimates of (C) recurrence-free and (D) cancer-specific survival in 440 patients with pT2 lymph node (LN)–negative UCB at RC stratified by pT2 substage. SE=standard error. European Urology 2010 58, 112-117DOI: (10.1016/j.eururo.2010.01.015) Copyright © 2010 European Association of Urology Terms and Conditions